Stereotaxis greenshoe exercised, raising stock offering to $66 million

By Angela McDaniels

Seattle, Feb. 1 - Stereotaxis Inc. said the underwriters of its recent follow-on stock offering have exercised their 500,000 share over-allotment option in full, raising the size of the deal to 5.5 million shares or $66 million.

The company sold 5 million shares in a spot follow-on sale on Jan. 26 at $12 per share via bookrunner Deutsche Bank Securities Inc. A.G. Edwards & Sons Inc. and HSBC Securities (USA) Inc. were co-managers.

St. Louis-based Stereotaxis makes cardiology instrument control systems for use in a hospital's interventional surgical suite to enhance the treatment of coronary artery disease and arrhythmias.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.